Sutajová, 2004 - Google Patents
Molecular characterization of a chromosome 1; 22 translocation in a patient with a phenotype resembling Costello syndromeSutajová, 2004
View PDF- Document ID
- 11892723954224755955
- Author
- Sutajová M
- Publication year
External Links
Snippet
In this work, a female patient with a phenotype resembling Costello syndrome and carrying an apparently balanced de novo translocation t (1; 22)(q24. 3; q13. 1) was studied. In general, balanced chromosomal rearrangements associated with a Mendelian disorder are …
- 206010067380 Costello syndrome 0 title abstract description 139
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7292836B6 (en) | MECP2E1 gene | |
AU2005314461A1 (en) | Methods and compositions for treating ocular disorders | |
US20030110526A1 (en) | Dysferlin mutations | |
US12116394B2 (en) | Loss of function mutations in KCNJ10 cause SeSAME, a human syndrome with sensory, neurological, and renal deficits | |
CA2438334C (en) | Ocular tear growth factor-like protein | |
JP2002511749A (en) | Tumor suppressor gene DBCCR1 at 9q32-33 | |
WO1999037764A2 (en) | New members of the glypican gene family | |
US5731192A (en) | Collagen COL4A6: gene, protein and method of detecting collagen deficiency | |
US5962230A (en) | Diagnosis and treatment of glaucoma | |
Sutajová | Molecular characterization of a chromosome 1; 22 translocation in a patient with a phenotype resembling Costello syndrome | |
WO1999002724A2 (en) | Methods for identifying genes expressed in selected lineages, and a novel genes identified using the methods | |
EP0905239B1 (en) | Gene encoding Afadin-1 | |
WO1999007854A2 (en) | Serine/threonine kinase, and uses related thereto | |
US6350867B1 (en) | Compositions and methods for enhancing osseous growth, repair and regeneration | |
US7122328B2 (en) | Gene involved in mineral deposition and uses thereof | |
US5830661A (en) | Diagnosis and treatment of glaucoma | |
JP2001508291A (en) | Methods for diagnosis and treatment of pathological conditions caused by insufficient ion transport | |
JP2005525079A (en) | ALS2 gene and amyotrophic lateral sclerosis type 2 | |
US7309783B2 (en) | Mammalian early developmental regulator gene | |
AU775409B2 (en) | Meg-3 protein | |
WO2002033071A1 (en) | Survivin-like polypeptides and dnas thereof | |
WO1996018735A2 (en) | Tgf-beta superfamily type ii receptor having binding affinity for bone morphogenic protein (bmp) | |
US20040053210A1 (en) | Genetic demonstration of requirement for nkx6.1, nkx2.2 and nkx6.2 in ventral neuron generation | |
WO1997046679A9 (en) | Cyclin-c variants, and diagnostic and therapeutic uses thereof | |
WO2003048196A2 (en) | Means and methods for diagnosing and treating craniofacial malformations |